News Releases

June 25, 2024

USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza

Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease RAHWAY, N.J., June 25, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the U.S. Department of Agriculture (USDA) approval of NOBIVAC® […]

June 17, 2024

Merck Animal Health Announces Launch and Availability of NOBIVAC® NXT Rabies in Canada

First-of-its-kind line of vaccines leverages state-of-the-art RNA-particle technology to protect cats and dogs from rabies RAHWAY, N.J., June 17, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the launch and availability of the […]

March 18, 2024

Merck Animal Health Marks Commitment to Rabies Elimination Through Donation of NOBIVAC® Rabies Vaccines to Mission Rabies

Rahway, NJ., March 18, 2024 – Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK) has announced a continued commitment to rabies elimination through a donation of NOBIVAC® rabies vaccines to the Mission Rabies program, a charity initiative of the Worldwide Veterinary Service (WVS). The donations will continue over the […]

March 15, 2024

Orally Administered BRAVECTO® (Fluralaner) 12-Week Chew Eliminated 100 Percent of Brown Dog Ticks from Infested Kennels Housing Treated Dogs in Recently Published Study

BRAVECTO eliminated kennel infestations of brown dog ticks (Rhipicephalus sanguineus sensu lato) External imidacloprid/flumethrin collar treatments failed to eliminate all ticks from kennels RAHWAY, N.J., March 15, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), […]

January 29, 2024

European Commission Approves Injectable Formulation of BRAVECTO® (Fluralaner) for Use in Dogs

Rahway, NJ., January 29, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the European Commission (EC) has approved BRAVECTO® (fluralaner) 150 mg/ml powder and solvent for suspension for injection for dogs. The product […]

January 24, 2024

Merck Animal Health Reaffirms its Commitment to the Poultry Industry and Future Poultry Talent at the International Production and Processing Expo (IPPE)

Rahway, NJ, January 24, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it will showcase its portfolio of innovative solutions to advance the poultry industry as well as offer future talent development opportunities […]

January 23, 2024

Merck Animal Health Announces WSAVA Michael J. Day Scholarship Recipient for 2023

Winning veterinary student set to investigate canine distemper virus maternal antibody transfer in dogs Rahway, NJ, January 23, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the 2023 recipient of the World Small […]